Breaking News

Crown Bioscience Expands and Renovates UK Facility

Increases capacity and expands the company’s current in vivo offering by 30%.

Author Image

By: Charlie Sternberg

Associate Editor

Crown Bioscience, a JSR Life Sciences company and contract research organization (CRO) in preclinical and translational drug development services, has completed the expansion and renovation of its Crown Bioscience United Kingdom facility.   The additional laboratory and office space will increase capacity and expand the company’s current in vivo offering by 30 percent and provide dedicated space for a newly acquired high frequency ultrasound unit – a specialized high-resolution imaging device de...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters